BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32098685)

  • 1. Corrigendum to "Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells" [Biomed. Pharmacother., v.123 (2020) 109794].
    Lopes TZ; de Moraes FR; Tedesco AC; Arni RK; Rahal P; Calmon MF
    Biomed Pharmacother; 2020 May; 125():110038. PubMed ID: 32098685
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells" [Biomed. Pharmacother. 123 (2020) 109794].
    Lopes TZ; de Moraes FR; Tedesco AC; Arni RK; Rahal P; Calmon MF
    Biomed Pharmacother; 2021 Apr; 136():111175. PubMed ID: 33358325
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling" [Biomed. Pharmacother. 116 (2019) 108749].
    Li Y; Zuo H; Wang H; Hu A
    Biomed Pharmacother; 2020 Mar; 123():109815. PubMed ID: 31932124
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion" [Biomed. Pharmacother. 82 (2016) 319-326].
    Ye T; Zhu S; Zhu Y; Feng Q; He B; Xiong Y; Zhao L; Zhang Y; Yu L; Yang L
    Biomed Pharmacother; 2019 Dec; 120():109510. PubMed ID: 31635901
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "XIAOPI formula promotes breast cancer chemosensitivity via inhibiting CXCL1/HMGB1-mediated autophagy" [Biomed. Pharmacother. 120 (2019) 109519].
    Wang N; Yang B; Muhetaer G; Wang S; Zheng Y; Lu J; Li M; Zhang F; Situ H; Lin Y; Wang Z
    Biomed Pharmacother; 2022 May; 149():112867. PubMed ID: 35370022
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice" [Biomed. Pharmacother. 118 (2019) 109206].
    Hou Q; Zhu S; Zhang C; Huang Y; Guo Y; Li P; Chen X; Wen Y; Han Q; Liu F
    Biomed Pharmacother; 2019 Oct; 118():109290. PubMed ID: 31471002
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Raw and salt-processed Achyranthes bidentata attenuate LPS-induced acute kidney injury by inhibiting ROS and apoptosis via an estrogen-like pathway [Biomed. Pharmacother. 129 (2020) 110403]".
    Wang S; Zeng M; Li B; Kan Y; Zhang B; Zheng X; Feng W
    Biomed Pharmacother; 2021 Sep; 141():111987. PubMed ID: 34412942
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis" [Biomed. Pharmacother. 92 (2017) 1119-1127].
    Liu S; Xiao Z; Ai F; Liu F; Chen X; Cao K; Ren W; Zhang X; Shu P; Zhang D
    Biomed Pharmacother; 2018 Mar; 99():1033-1036. PubMed ID: 29398246
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway" [Biomed. Pharmacother. 128 (2020) 110216].
    Cui L; Li C; Zhuo Y; Yang L; Cui N; Li Y; Zhang S
    Biomed Pharmacother; 2020 Oct; 130():110685. PubMed ID: 32893050
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma "in vitro" [Biomed. Pharmacother. 66 (2012) 64-69].
    Akagi EM; de Sá Júnior PL; Simons SM; Bellini MH; Barreto SA; Chudzinski-Tavassi AM
    Biomed Pharmacother; 2019 Oct; 118():109108. PubMed ID: 31235339
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Co-encapsulation of dual drug loaded in MLNPs: Implication on sustained drug release and effectively inducing apoptosis in oral carcinoma cells" [Biomed. Pharmacother. 104 (2018) 661-671].
    Sivaraj M; Mukherjee A; Mariappan R; Govindhan A; Murugaraj J
    Biomed Pharmacother; 2020 May; 125():109969. PubMed ID: 32088023
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer" [Biomed. Pharmacother. 103 (2018) 1369-1375].
    Han T; Lin J; Wang Y; Fan Q; Sun H; Tao Y; Sun C
    Biomed Pharmacother; 2022 Sep; 153():113318. PubMed ID: 35738965
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Antioxidants activities of phytochemicals perspective modulation of autophagy and apoptosis to treating cancer" [Biomed. Pharmacother. 174 (2024) 116497].
    Ahmed KR; Rahman MM; Islam MN; Fahim MMH; Rahman MA; Kim B
    Biomed Pharmacother; 2024 May; ():116757. PubMed ID: 38797597
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Corrigendum to "Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells" [Biomed. Pharmacother. 98 (2018) 36-44]'.
    Zhao Y; Tang H; Zeng X; Ye D; Liu J
    Biomed Pharmacother; 2022 Sep; 153():113329. PubMed ID: 35760645
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "miR-152 regulated glioma cell proliferation and apoptosis via Runx2 mediated by DNMT1" [Biomed. Pharmacother. 92 (2017) 690-695].
    Zhang P; Sun H; Yang B; Luo W; Liu Z; Wang J; Zuo Y
    Biomed Pharmacother; 2020 Jun; 126():110090. PubMed ID: 32201084
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity" [Biomed. Pharmacother. 105 (2018) 758-765].
    Qin J; Shi H; Xu Y; Zhao F; Wang Q
    Biomed Pharmacother; 2019 Oct; 118():109107. PubMed ID: 31227337
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells" [Biomed. Pharmacother. 84 (2016) 947-953].
    Wang J; Wang B; Chen LQ; Yang J; Gong ZQ; Zhao XL; Zhang CQ; Du KL
    Biomed Pharmacother; 2020 Aug; 128():110175. PubMed ID: 32475632
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes" [Biomed. Pharmacother. 126 (2020) 110066].
    Li X; Shang D; Shen H; Song J; Hao G; Tian Y
    Biomed Pharmacother; 2020 Oct; 130():110858. PubMed ID: 33054976
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer" [Biomed Pharmacother. 97 (2018) 1275-1281].
    Wu J; Shuang Z; Zhao J; Tang H; Liu P; Zhang L; Xie X; Xiao X
    Biomed Pharmacother; 2020 Jul; 127():110174. PubMed ID: 32423656
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway" [Biomed. Pharmacother. 123 (2020) 109790].
    Cai H; Yan L; Liu N; Xu M; Cai H
    Biomed Pharmacother; 2020 Jun; 126():110077. PubMed ID: 32173085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.